The Medical & Scientific Operations Division has had a long and rich history, dating back to 1955. The Medical & Scientific Operations has provided the Kingdom’s healthcare sector with highest quality medical equipment .
Since the inception of its pharmaceutical distribution activities in 1945, Abdulrehman Algosaibi G.T.C has been regarded as a leading pharmaceutical supplier, connecting patients with pharmaceutical products of the highest quality across the Kingdom.
The Dental Operations is proud to represent some of the leading global Dental companies. The Dental Division has a comprehensive range of dental equipment and supplies.
The Veterinary Division deals in a variety of vaccines and pharmaceuticals to meet the growing needs of the poultry and dairy farming throughout the Kingdom.
Abdulrehman Algosaibi G.T.C.’s Pharmacovigilance Department helps monitor the safety of the products we distribute in Saudi Arabia. Established in 2017, the team works with multinational marketing authorization holders to support patient safety and the reporting responsibilities that accompany pharmaceutical distribution.
Our work brings together safety monitoring, adverse-event reporting channels and coordination with pharmaceutical partners. The department operates in line with the Saudi Food and Drug Authority’s Good Pharmacovigilance Practices. Our service approach includes 24/7 safety oversight for the products entrusted to us.
Partners can discuss their portfolio with our PV team to confirm the products covered, the reporting arrangements and each party’s responsibilities. That conversation helps establish a clear scope for the relationship from the outset.
Our head office is in Riyadh. Partner-published Saudi safety contacts also identify our Pharmacovigilance Department, including Mirum Pharmaceuticals and Dr. Pfleger.
An example of our earlier pharmacovigilance work appears in an SFDA-hosted PecFent healthcare professional guide, approved in April 2019. It names Abdulrehman Algosaibi G.T.C. and a company pharmacovigilance contact. The guide records the arrangements at that time; please use the current reporting channels on this page for safety reports.
For a wider view of our work, see our Pharmaceutical & Biological Operations. Our Life Sciences Business Quality Policy sets out our commitments to patient safety, product quality and traceability.
If you are comparing pharmacovigilance companies in Saudi Arabia, start with the needs of your portfolio. Ask who will handle safety reports, how the local team can be reached and how responsibilities will be shared with the marketing authorization holder. Relevant experience and clear reporting arrangements matter more than a broad claim to be the best.
At G.T.C., our PV work forms part of our healthcare distribution business. Tell us which products and Saudi market activities you need to discuss, and our team will confirm the available support and scope.
Please use our dedicated safety channels:
For product quality complaints, email qualitycomplaints@aralgosaibico.com. For customer service, call 920011229.
Our dedicated department monitors the safety of distributed products and coordinates with multinational marketing authorization holders. Speak with the team to confirm the coverage and responsibilities for a particular portfolio.
Use our corporate contact page and ask for the PV team. Include the products and Saudi market activities you would like to discuss. Suspected adverse events should be reported through the dedicated safety channels above.
Explore our healthcare distribution overview or consult the SFDA’s pharmacovigilance information for regulatory background.